nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Hypoxia—Thiotepa—sarcoma	0.031	0.031	CcSEcCtD
Levorphanol—Cyanosis—Etoposide—sarcoma	0.02	0.02	CcSEcCtD
Levorphanol—Respiratory failure—Vincristine—sarcoma	0.0178	0.0178	CcSEcCtD
Levorphanol—Apnoea—Etoposide—sarcoma	0.0167	0.0167	CcSEcCtD
Levorphanol—Coma—Vincristine—sarcoma	0.016	0.016	CcSEcCtD
Levorphanol—Lethargy—Dactinomycin—sarcoma	0.0145	0.0145	CcSEcCtD
Levorphanol—Cardiac arrest—Thiotepa—sarcoma	0.0136	0.0136	CcSEcCtD
Levorphanol—Urinary retention—Thiotepa—sarcoma	0.0136	0.0136	CcSEcCtD
Levorphanol—Cardiac arrest—Vincristine—sarcoma	0.0121	0.0121	CcSEcCtD
Levorphanol—Urinary retention—Vincristine—sarcoma	0.0121	0.0121	CcSEcCtD
Levorphanol—Hypokinesia—Epirubicin—sarcoma	0.0117	0.0117	CcSEcCtD
Levorphanol—Dysuria—Thiotepa—sarcoma	0.0116	0.0116	CcSEcCtD
Levorphanol—Hypokinesia—Doxorubicin—sarcoma	0.0109	0.0109	CcSEcCtD
Levorphanol—Renal failure—Thiotepa—sarcoma	0.0108	0.0108	CcSEcCtD
Levorphanol—Dysuria—Vincristine—sarcoma	0.0102	0.0102	CcSEcCtD
Levorphanol—Cardiac arrest—Etoposide—sarcoma	0.00976	0.00976	CcSEcCtD
Levorphanol—Sweating—Vincristine—sarcoma	0.00936	0.00936	CcSEcCtD
Levorphanol—Renal failure—Mitoxantrone—sarcoma	0.00935	0.00935	CcSEcCtD
Levorphanol—Sweating—Mitoxantrone—sarcoma	0.00912	0.00912	CcSEcCtD
Levorphanol—Flushing—Dactinomycin—sarcoma	0.00911	0.00911	CcSEcCtD
Levorphanol—Arrhythmia—Thiotepa—sarcoma	0.00883	0.00883	CcSEcCtD
Levorphanol—Bradycardia—Mitoxantrone—sarcoma	0.00869	0.00869	CcSEcCtD
Levorphanol—Thinking abnormal—Epirubicin—sarcoma	0.00866	0.00866	CcSEcCtD
Levorphanol—Tension—Thiotepa—sarcoma	0.00845	0.00845	CcSEcCtD
Levorphanol—Dyskinesia—Epirubicin—sarcoma	0.00844	0.00844	CcSEcCtD
Levorphanol—Nervousness—Thiotepa—sarcoma	0.00836	0.00836	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—sarcoma	0.00801	0.00801	CcSEcCtD
Levorphanol—Agitation—Thiotepa—sarcoma	0.00791	0.00791	CcSEcCtD
Levorphanol—Injection site reaction—Epirubicin—sarcoma	0.00788	0.00788	CcSEcCtD
Levorphanol—Abnormal dreams—Epirubicin—sarcoma	0.00784	0.00784	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—sarcoma	0.00781	0.00781	CcSEcCtD
Levorphanol—Renal failure—Etoposide—sarcoma	0.00778	0.00778	CcSEcCtD
Levorphanol—Arrhythmia—Mitoxantrone—sarcoma	0.00763	0.00763	CcSEcCtD
Levorphanol—Convulsion—Thiotepa—sarcoma	0.00746	0.00746	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—sarcoma	0.00729	0.00729	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—sarcoma	0.00725	0.00725	CcSEcCtD
Levorphanol—Coma—Epirubicin—sarcoma	0.00725	0.00725	CcSEcCtD
Levorphanol—Confusional state—Thiotepa—sarcoma	0.00708	0.00708	CcSEcCtD
Levorphanol—Agitation—Vincristine—sarcoma	0.00701	0.00701	CcSEcCtD
Levorphanol—Abnormal vision—Epirubicin—sarcoma	0.00692	0.00692	CcSEcCtD
Levorphanol—Mental disability—Epirubicin—sarcoma	0.00688	0.00688	CcSEcCtD
Levorphanol—Tachycardia—Thiotepa—sarcoma	0.00686	0.00686	CcSEcCtD
Levorphanol—Coma—Doxorubicin—sarcoma	0.0067	0.0067	CcSEcCtD
Levorphanol—Convulsion—Vincristine—sarcoma	0.00661	0.00661	CcSEcCtD
Levorphanol—Flushing—Etoposide—sarcoma	0.00659	0.00659	CcSEcCtD
Levorphanol—Convulsion—Mitoxantrone—sarcoma	0.00644	0.00644	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—sarcoma	0.0064	0.0064	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—sarcoma	0.00637	0.00637	CcSEcCtD
Levorphanol—Dyspepsia—Thiotepa—sarcoma	0.00618	0.00618	CcSEcCtD
Levorphanol—Confusional state—Mitoxantrone—sarcoma	0.00612	0.00612	CcSEcCtD
Levorphanol—Hyperhidrosis—Vincristine—sarcoma	0.00602	0.00602	CcSEcCtD
Levorphanol—Constipation—Thiotepa—sarcoma	0.00601	0.00601	CcSEcCtD
Levorphanol—Shock—Mitoxantrone—sarcoma	0.00597	0.00597	CcSEcCtD
Levorphanol—Muscle spasms—Etoposide—sarcoma	0.00595	0.00595	CcSEcCtD
Levorphanol—Tachycardia—Mitoxantrone—sarcoma	0.00592	0.00592	CcSEcCtD
Levorphanol—Lethargy—Epirubicin—sarcoma	0.00587	0.00587	CcSEcCtD
Levorphanol—Hyperhidrosis—Mitoxantrone—sarcoma	0.00587	0.00587	CcSEcCtD
Levorphanol—Hypotension—Vincristine—sarcoma	0.00582	0.00582	CcSEcCtD
Levorphanol—Feeling abnormal—Thiotepa—sarcoma	0.00579	0.00579	CcSEcCtD
Levorphanol—Diplopia—Epirubicin—sarcoma	0.00576	0.00576	CcSEcCtD
Levorphanol—Feeling abnormal—Dactinomycin—sarcoma	0.00575	0.00575	CcSEcCtD
Levorphanol—Gastrointestinal pain—Thiotepa—sarcoma	0.00574	0.00574	CcSEcCtD
Levorphanol—Gastrointestinal pain—Dactinomycin—sarcoma	0.0057	0.0057	CcSEcCtD
Levorphanol—Hypotension—Mitoxantrone—sarcoma	0.00567	0.00567	CcSEcCtD
Levorphanol—Affect lability—Epirubicin—sarcoma	0.00567	0.00567	CcSEcCtD
Levorphanol—Insomnia—Vincristine—sarcoma	0.00563	0.00563	CcSEcCtD
Levorphanol—Urticaria—Thiotepa—sarcoma	0.00558	0.00558	CcSEcCtD
Levorphanol—Abdominal pain—Thiotepa—sarcoma	0.00555	0.00555	CcSEcCtD
Levorphanol—Abdominal pain—Dactinomycin—sarcoma	0.00551	0.00551	CcSEcCtD
Levorphanol—Cardiac arrest—Epirubicin—sarcoma	0.00547	0.00547	CcSEcCtD
Levorphanol—Mood swings—Epirubicin—sarcoma	0.00545	0.00545	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—sarcoma	0.00543	0.00543	CcSEcCtD
Levorphanol—Convulsion—Etoposide—sarcoma	0.00536	0.00536	CcSEcCtD
Levorphanol—Dyspepsia—Mitoxantrone—sarcoma	0.00534	0.00534	CcSEcCtD
Levorphanol—Constipation—Vincristine—sarcoma	0.00533	0.00533	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—sarcoma	0.00533	0.00533	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—sarcoma	0.00524	0.00524	CcSEcCtD
Levorphanol—Constipation—Mitoxantrone—sarcoma	0.00519	0.00519	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vincristine—sarcoma	0.00509	0.00509	CcSEcCtD
Levorphanol—Confusional state—Etoposide—sarcoma	0.00509	0.00509	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—sarcoma	0.00506	0.00506	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—sarcoma	0.00505	0.00505	CcSEcCtD
Levorphanol—Feeling abnormal—Mitoxantrone—sarcoma	0.005	0.005	CcSEcCtD
Levorphanol—Pruritus—Thiotepa—sarcoma	0.00497	0.00497	CcSEcCtD
Levorphanol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00496	0.00496	CcSEcCtD
Levorphanol—Tachycardia—Etoposide—sarcoma	0.00493	0.00493	CcSEcCtD
Levorphanol—Abdominal pain—Vincristine—sarcoma	0.00492	0.00492	CcSEcCtD
Levorphanol—Hyperhidrosis—Etoposide—sarcoma	0.00488	0.00488	CcSEcCtD
Levorphanol—Urticaria—Mitoxantrone—sarcoma	0.00482	0.00482	CcSEcCtD
Levorphanol—Abdominal pain—Mitoxantrone—sarcoma	0.0048	0.0048	CcSEcCtD
Levorphanol—Hypotension—Etoposide—sarcoma	0.00472	0.00472	CcSEcCtD
Levorphanol—Dysuria—Epirubicin—sarcoma	0.00465	0.00465	CcSEcCtD
Levorphanol—Dizziness—Thiotepa—sarcoma	0.00465	0.00465	CcSEcCtD
Levorphanol—Vomiting—Thiotepa—sarcoma	0.00447	0.00447	CcSEcCtD
Levorphanol—Vomiting—Dactinomycin—sarcoma	0.00443	0.00443	CcSEcCtD
Levorphanol—Rash—Thiotepa—sarcoma	0.00443	0.00443	CcSEcCtD
Levorphanol—Dermatitis—Thiotepa—sarcoma	0.00443	0.00443	CcSEcCtD
Levorphanol—Rash—Dactinomycin—sarcoma	0.0044	0.0044	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—sarcoma	0.00436	0.00436	CcSEcCtD
Levorphanol—Constipation—Etoposide—sarcoma	0.00432	0.00432	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—sarcoma	0.0043	0.0043	CcSEcCtD
Levorphanol—Sweating—Epirubicin—sarcoma	0.00425	0.00425	CcSEcCtD
Levorphanol—Nausea—Thiotepa—sarcoma	0.00417	0.00417	CcSEcCtD
Levorphanol—Feeling abnormal—Etoposide—sarcoma	0.00416	0.00416	CcSEcCtD
Levorphanol—Nausea—Dactinomycin—sarcoma	0.00414	0.00414	CcSEcCtD
Levorphanol—Gastrointestinal pain—Etoposide—sarcoma	0.00413	0.00413	CcSEcCtD
Levorphanol—Dizziness—Vincristine—sarcoma	0.00412	0.00412	CcSEcCtD
Levorphanol—Bradycardia—Epirubicin—sarcoma	0.00405	0.00405	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—sarcoma	0.00403	0.00403	CcSEcCtD
Levorphanol—Urticaria—Etoposide—sarcoma	0.00401	0.00401	CcSEcCtD
Levorphanol—Abdominal pain—Etoposide—sarcoma	0.00399	0.00399	CcSEcCtD
Levorphanol—Vomiting—Vincristine—sarcoma	0.00396	0.00396	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—sarcoma	0.00393	0.00393	CcSEcCtD
Levorphanol—Rash—Vincristine—sarcoma	0.00393	0.00393	CcSEcCtD
Levorphanol—Dermatitis—Vincristine—sarcoma	0.00392	0.00392	CcSEcCtD
Levorphanol—Vomiting—Mitoxantrone—sarcoma	0.00386	0.00386	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—sarcoma	0.00384	0.00384	CcSEcCtD
Levorphanol—Rash—Mitoxantrone—sarcoma	0.00383	0.00383	CcSEcCtD
Levorphanol—Dermatitis—Mitoxantrone—sarcoma	0.00382	0.00382	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—sarcoma	0.00375	0.00375	CcSEcCtD
Levorphanol—Nausea—Vincristine—sarcoma	0.0037	0.0037	CcSEcCtD
Levorphanol—Flushing—Epirubicin—sarcoma	0.0037	0.0037	CcSEcCtD
Levorphanol—Nausea—Mitoxantrone—sarcoma	0.0036	0.0036	CcSEcCtD
Levorphanol—Pruritus—Etoposide—sarcoma	0.00357	0.00357	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—sarcoma	0.00356	0.00356	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—sarcoma	0.00355	0.00355	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—sarcoma	0.00342	0.00342	CcSEcCtD
Levorphanol—Tension—Epirubicin—sarcoma	0.0034	0.0034	CcSEcCtD
Levorphanol—Nervousness—Epirubicin—sarcoma	0.00337	0.00337	CcSEcCtD
Levorphanol—Dizziness—Etoposide—sarcoma	0.00334	0.00334	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—sarcoma	0.00333	0.00333	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—sarcoma	0.00329	0.00329	CcSEcCtD
Levorphanol—Vomiting—Etoposide—sarcoma	0.00321	0.00321	CcSEcCtD
Levorphanol—Agitation—Epirubicin—sarcoma	0.00319	0.00319	CcSEcCtD
Levorphanol—Rash—Etoposide—sarcoma	0.00318	0.00318	CcSEcCtD
Levorphanol—Dermatitis—Etoposide—sarcoma	0.00318	0.00318	CcSEcCtD
Levorphanol—Tension—Doxorubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—sarcoma	0.00311	0.00311	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—sarcoma	0.00308	0.00308	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—sarcoma	0.00306	0.00306	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—sarcoma	0.003	0.003	CcSEcCtD
Levorphanol—Nausea—Etoposide—sarcoma	0.003	0.003	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—sarcoma	0.00295	0.00295	CcSEcCtD
Levorphanol—Dry mouth—Epirubicin—sarcoma	0.00289	0.00289	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—sarcoma	0.00285	0.00285	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—sarcoma	0.00283	0.00283	CcSEcCtD
Levorphanol—Shock—Epirubicin—sarcoma	0.00278	0.00278	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—sarcoma	0.00278	0.00278	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—sarcoma	0.00273	0.00273	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—sarcoma	0.00267	0.00267	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—sarcoma	0.00264	0.00264	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—sarcoma	0.00264	0.00264	CcSEcCtD
Levorphanol—Shock—Doxorubicin—sarcoma	0.00258	0.00258	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—sarcoma	0.00245	0.00245	CcSEcCtD
Levorphanol—Constipation—Epirubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—sarcoma	0.00237	0.00237	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Levorphanol—Pruritus—Epirubicin—sarcoma	0.002	0.002	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Levorphanol—Vomiting—Epirubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Levorphanol—Rash—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Levorphanol—Nausea—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Levorphanol—Rash—Doxorubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
